# Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist

> **NCT00303394** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 72 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** IL-1Ra

## Key facts

- **NCT ID:** NCT00303394
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 72 (—)
- **Last updated:** 2007-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00303394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00303394, "Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00303394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*